Vanguard Group Inc Opti Nose, Inc. Put Options Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding OPTN
# of Institutions
73Shares Held
59.6MCall Options Held
0Put Options Held
0-
Mvm Partners, LLC Boston, MA14.6MShares$15.2 Million12.71% of portfolio
-
Great Point Partners LLC Greenwich, CT8.79MShares$9.14 Million3.14% of portfolio
-
Black Rock Inc. New York, NY4.28MShares$4.45 Million0.0% of portfolio
-
Bleichroeder LP New York, NY4.05MShares$4.21 Million1.83% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY3.9MShares$4.06 Million0.69% of portfolio
About OptiNose, Inc.
- Ticker OPTN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 83,277,504
- Market Cap $86.6M
- Description
- OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...